According to Avadel Pharmaceuticals
's latest financial reports the company has $87.73 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $87.73 M | -514.94% |
2022-12-31 | $-21.15 M | -127.02% |
2021-12-31 | $78.24 M | -51.78% |
2020-12-31 | $0.16 B | -655.72% |
2019-12-31 | $-29.2 M | -1150.32% |
2018-12-31 | $2.78 M | -96.75% |
2017-12-31 | $85.58 M | 103.43% |
2016-12-31 | $42.06 M | -39.15% |
2015-12-31 | $69.13 M | 177.7% |
2014-12-31 | $24.89 M | -361.72% |
2013-12-31 | $-9.52 M | -131.18% |
2012-12-31 | $30.5 M | 2.38% |
2011-12-31 | $29.79 M | -17.93% |
2010-12-31 | $36.3 M | -19.08% |
2009-12-31 | $44.86 M | -7.59% |
2008-12-31 | $48.54 M | -11.13% |
2007-12-31 | $54.62 M | -25.2% |
2006-12-31 | $73.02 M | -15.73% |
2005-12-31 | $86.65 M | -25.78% |
2004-12-31 | $0.11 B | 26.83% |
2003-12-31 | $92.06 M | 649.32% |
2002-12-31 | $12.28 M | 63.62% |
2001-12-31 | $7.5 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 1,483.36% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $10.67 M | -87.84% | ๐บ๐ธ USA |